NuMedii NuMedii Inks Single-Cell Sequencing Collaborations With Yale, Brigham and Women's Hospital NuMedii will use its AI technology in combination with single-cell data to identify biomarkers and therapeutics for idiopathic pulmonary fibrosis. Cyclica Adds New Features to Drug-Discovery Software, Preps for SaaS Product Launch in 2017 Premium Cyclica will soon begin testing a commercial version of its services software this summer ahead of a full launch planned for next year. UCSC Pediatric Cancer Project to Use Pan-Cancer Analysis Approach to Match Patients to Treatment Premium Using funds from the California precision medicine initiative, the group will use its bioinformatics expertise to match patients to treatments in pediatric clinical trials. California Precision Medicine Effort Awards $2.4M to Pediatric Cancer, Infectious Disease Projects The initiative aims to integrate clinical, genomic, environmental, and other data from patients to help determine disease mechanisms and develop precise therapies. Q&A: Atul Butte on New Roles at UCSF's Computational and Clinical Informatics Centers Premium In April, Butte became director of UCSF's Institute for Computational Health Sciences and executive director of clinical informatics for UC Health Sciences and Services. Nov 8, 2013 Thomson Reuters, NuMedii Ink Partnership Around Drug Repurposing Premium Jul 8, 2013 Q&A: Stanford's Atul Butte on the Importance of Open Data for Biomedical Research Premium Jun 26, 2013 NuMedii Raises $3.5M in Series A Financing Oct 5, 2012 Aptalis Pharma taps NuMedii to Select Candidates for Drug Research Premium Dec 2, 2011 Stanford Spinoff NuMedii Commercializes Drug-Repurposing Algorithm, Seeks Pharma Partnerships Premium Aug 24, 2011 Stanford Spinout NuMedii Seeks Pharma Partners to Use PGx Repositioning Algorithm in Drug Pipelines Premium Breaking News Genetic Loci With Link to Bowel Movement Frequency May Point to GI Condition Treatments Rebus Biosystems Acquires IP, Assay Assets of EEL Transcriptomics Genedrive Rapid Molecular COVID-19 Test Receives CE Mark Nomic Bio Closes $17M Series A Round Pacific Biosciences, UCLA Collaborate on Rare Disease Diagnostics Foundation Medicine Test Nabs FDA Approval as CDx for BRAF Inhibitor Therapeutics for Melanoma The Scan Back as Director A court has reinstated Nicole Boivin as director of the Max Planck Institute for the Science of Human History, Science reports. Research, But Implementation? Francis Collins reflects on his years as the director of the US National Institutes of Health with NPR. For the False Negatives The Guardian writes that the UK Health Security Agency is considering legal action against the lab that reported thousands of false negative COVID-19 test results. Genome Biology Papers Present Epigenetics Benchmarking Resource, Genomic Architecture Maps of Peanuts, More In Genome Biology this week: DNA methylation data for seven reference cell lines, three-dimensional genome architecture maps of peanut lines, and more.